ERG and cancer: It has been shown that soluble guanylyl cyclase (sGC) is strongly associated with the TMPRSS2-ERG fusion in clinical PCa cohorts and that the sGC-mediated NO-cGMP pathway is a critical downstream effector of ERG in promoting cancer cell proliferation and tumorigenesis [44].